Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Journal of Hepatology|August 11, 2020
Reply to: Correspondence on "High rates of 30-day mortality in patients with cirrhosis and COVID-19"Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico, et al.
Gut|October 8, 2020
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2026
Breaking Barriers: Equitable Treatment Access Achieves Survival Parity in HCC for People With HIVMassimo Iavarone, Eleonora Alimenti, Alessandro Soria
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
World Journal of Gastroenterology|May 12, 2020
Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitorsFederico Piñero, Marcelo Silva, Massimo Iavarone
Hepatology (Baltimore, Md.)|January 10, 2023
Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moonGiuseppe Cabibbo, Ciro Celsa, Eleonora Alimenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2015
Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectivesCristina Della Corte, Michela Triolo, Massimo Iavarone, et al.
Journal of Hepatology|August 15, 2017
Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrenceMaria Francesca Donato, Federica Invernizzi, Giorgio Rossi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2024
Erratum to "Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma" [Digestive and Liver Disease 56 (2024) 2011-2021]Eleonora Alimenti, Erica Nicola Lynch, Leonardo Antonio Natola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2022
Hepatic splenosis mimicking hepatocellular carcinoma in metabolic associated fatty liver diseaseTommaso Pessarelli, Silvia Crespi, Barbara Antonelli, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Journal of Hepatology|August 11, 2020
Reply to: Correspondence on "High rates of 30-day mortality in patients with cirrhosis and COVID-19"Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico, et al.
Gut|October 8, 2020
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2026
Breaking Barriers: Equitable Treatment Access Achieves Survival Parity in HCC for People With HIVMassimo Iavarone, Eleonora Alimenti, Alessandro Soria
Gastroenterology|December 7, 2007
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosisMauro Viganò, Alessio Aghemo, Massimo Iavarone
World Journal of Gastroenterology|May 12, 2020
Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitorsFederico Piñero, Marcelo Silva, Massimo Iavarone
Hepatology (Baltimore, Md.)|January 10, 2023
Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moonGiuseppe Cabibbo, Ciro Celsa, Eleonora Alimenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 20, 2015
Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectivesCristina Della Corte, Michela Triolo, Massimo Iavarone, et al.
Journal of Hepatology|August 15, 2017
Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrenceMaria Francesca Donato, Federica Invernizzi, Giorgio Rossi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2024
Erratum to "Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma" [Digestive and Liver Disease 56 (2024) 2011-2021]Eleonora Alimenti, Erica Nicola Lynch, Leonardo Antonio Natola, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 14, 2022
Hepatic splenosis mimicking hepatocellular carcinoma in metabolic associated fatty liver diseaseTommaso Pessarelli, Silvia Crespi, Barbara Antonelli, et al.
Pageof 15